Chime, Polpharma Partner to Boost Biosimilar Development
April 16, 2025
Accelerate Polpharma Biologics biosimilar program from IND to commercial manufacturing Chime Biologics, a leading global CDMO that enables its partners’ success in biologics, is pleased